‘We Need To Move With The Times’: Cell & Gene Therapy Catapult CEO On UK’s Regulatory Overhaul

 
• By Eliza Slawther
  
Headshot of Matthew Durdy
Matthew Durdy is CEO of the UK Cell and Gene Therapy Catapult • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Interviews

More from Cell & Gene Therapies